Detalhe da pesquisa
1.
Predictive model for treatment outcomes of peripheral T-cell lymphoma, not otherwise specified, in Taiwanese patients.
J Formos Med Assoc
; 123(2): 188-197, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37558588
2.
Primary breast diffuse large B-cell lymphoma characterized by CNS relapse and successful hematopoietic stem cell transplantation salvage therapy.
J Formos Med Assoc
; 2024 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38296697
3.
Children with chronic myeloid leukaemia treated with front-line imatinib have a slower molecular response and comparable survival compared with adults: a multicenter experience in Taiwan.
Br J Cancer
; 128(7): 1294-1300, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36717672
4.
Comparison of molecular responses and outcomes between BCR::ABL1 e14a2 and e13a2 transcripts in chronic myeloid leukemia.
Cancer Sci
; 113(10): 3518-3527, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35869805
5.
A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohort.
Am J Hematol
; 97(9): 1159-1169, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35726449
6.
Application of comprehensive geriatric assessment in predicting early mortality among elder patients with B-cell lymphoma receiving immunochemotherapy.
Eur J Haematol
; 105(4): 399-407, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32472712
7.
Impact of Platelet Counts, Surgical Methods, and Preoperative Platelet Transfusion on the Outcome of Splenectomy for Immune Thrombocytopenia.
Acta Haematol
; 143(5): 465-471, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31910413
8.
Distinct immunoglobulin heavy chain variable region gene repertoire and lower frequency of del(11q) in Taiwanese patients with chronic lymphocytic leukaemia.
Br J Haematol
; 187(1): 82-92, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31230372
9.
Pharmacokinetic study of bortezomib administered intravenously in Taiwanese patients with multiple myeloma.
Hematol Oncol
; 36(1): 238-244, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28626947
10.
Immune thrombocytopenia: Effectiveness of frontline steroids and comparison of azathioprine, splenectomy, and rituximab as second-line treatment.
Eur J Haematol
; 101(4): 549-555, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30007087
11.
Extranodal NK/T-cell lymphoma, nasal type: Clinical features, outcome, and prognostic factors in 101 cases.
Eur J Haematol
; 101(3): 379-388, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29908084
12.
Pneumocystis jirovecii pneumonia in patients with acute myeloid leukaemia.
Intern Med J
; 48(1): 81-83, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29314523
13.
Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse.
Blood
; 126(22): 2491-501, 2015 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26438511
14.
Clinical Features and Recurrence Pattern of Perianal Abscess in Patients with Acute Myeloid Leukemia.
Acta Haematol
; 138(1): 10-13, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28586772
15.
Concordance of two approaches in monitoring of minimal residual disease in B-precursor acute lymphoblastic leukemia: Fusion transcripts and leukemia-associated immunophenotypes.
J Formos Med Assoc
; 116(10): 774-781, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28063722
16.
No association between ECSIT germline mutations and hemophagocytic lymphohistiocytosis in natural killer/T-cell lymphoma.
Haematologica
; 106(6): 1737-1739, 2021 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054138
17.
Cyclophosphamide plus granulocyte-colony stimulating factor for hematopoietic stem cell mobilization in patients with multiple myeloma.
J Clin Apher
; 31(5): 423-8, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26340986
18.
Clonal leukemic evolution in myelodysplastic syndromes with TET2 and IDH1/2 mutations.
Haematologica
; 99(1): 28-36, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23996483
19.
Clinical features of testicular lymphoma.
Acta Haematol
; 131(3): 187-92, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24247653
20.
Treatment outcome and germline predictive factors of ropeginterferon alpha-2b in myeloproliferative neoplasm patients.
Cancer Med
; 13(7): e7166, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38572926